Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Journal of Pharmacokinetics and Pharmacodynamics|October 28, 2010
Quantitative clinical pharmacology is transforming drug regulationCarl C PeckThe AAPS Journal|February 19, 2025
Bioequivalence of ANDA Data using a Non-Informative Bayesian Procedure (BEST) Compared with the Two One‑Sided t‑Tests (TOST)Jing Wang, Gregory Campbell, Jae H Lee, et al.British Journal of Clinical Pharmacology|July 11, 2019
Report on the current status of the use of real-world data (RWD) and real-world evidence (RWE) in drug development and regulationAlasdair M Breckenridge, Ross A Breckenridge, Carl C PeckThe AAPS Journal|December 16, 2005
Evidence of effectiveness: how much can we extrapolate from existing studies?Howard Lee, Dong-Seok Yim, Honghui Zhou, et al.Journal of Biopharmaceutical Statistics|August 12, 2011
Bayesian statistics in medical devices: innovation sparked by the FDAGregory CampbellJournal of Biopharmaceutical Statistics|December 29, 2007
Statistics in the world of medical devices: the contrast with pharmaceuticalsGregory CampbellJournal of Biopharmaceutical Statistics|October 8, 2004
Some statistical and regulatory issues in the evaluation of genetic and genomic testsGregory CampbellPhysiological Reports|March 1, 2018
Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamicsSergey Aksenov, Carl C Peck, Ulf G Eriksson, et al.Drug Design, Development and Therapy|December 21, 2016
Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013Hoon Young Suh, Carl C Peck, Kyung-Sang Yu, et al.Clinical Pharmacology and Therapeutics|April 24, 2003
Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysisHoward Lee, Hui C Kimko, Mark Rogge, et al.Pageof 4